Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Cardiac natriuretic peptides

Research output: Contribution to journalReviewResearchpeer-review

  1. Advances in lipid-lowering therapy through gene-silencing technologies

    Research output: Contribution to journalReviewResearchpeer-review

  2. Natriuretic peptides in cardiometabolic regulation and disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Third universal definition of myocardial infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. An atlas of O-linked glycosylation on peptide hormones reveals diverse biological roles

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Jens P Goetze
  • Benoit G Bruneau
  • Hugo R Ramos
  • Tsuneo Ogawa
  • Mercedes Kuroski de Bold
  • Adolfo J de Bold
View graph of relations

Investigations into the mixed muscle-secretory phenotype of cardiomyocytes from the atrial appendages of the heart led to the discovery that these cells produce, in a regulated manner, two polypeptide hormones - the natriuretic peptides - referred to as atrial natriuretic factor or atrial natriuretic peptide (ANP) and brain or B-type natriuretic peptide (BNP), thereby demonstrating an endocrine function for the heart. Studies on the gene encoding ANP (NPPA) initiated the field of modern research into gene regulation in the cardiovascular system. Additionally, ANP and BNP were found to be the natural ligands for cell membrane-bound guanylyl cyclase receptors that mediate the effects of natriuretic peptides through the generation of intracellular cGMP, which interacts with specific enzymes and ion channels. Natriuretic peptides have many physiological actions and participate in numerous pathophysiological processes. Important clinical entities associated with natriuretic peptide research include heart failure, obesity and systemic hypertension. Plasma levels of natriuretic peptides have proven to be powerful diagnostic and prognostic biomarkers of heart disease. Development of pharmacological agents that are based on natriuretic peptides is an area of active research, with vast potential benefits for the treatment of cardiovascular disease.

Original languageEnglish
JournalNature Reviews Cardiology
Volume17
Issue number11
Pages (from-to)698-717
Number of pages20
ISSN1759-5002
DOIs
Publication statusPublished - Nov 2020

    Research areas

  • Animals, Atrial Appendage/cytology, Atrial Fibrillation/metabolism, Atrial Natriuretic Factor/genetics, Atrial Remodeling, Biomarkers/metabolism, Cyclic GMP/metabolism, Diabetes Mellitus/metabolism, Fibrosis, Gene Expression Regulation, Developmental, Heart Atria/cytology, Heart Failure/metabolism, Humans, Hypertension/metabolism, Lipid Metabolism/physiology, Metabolic Syndrome/metabolism, Mice, Myocardium/metabolism, Myocytes, Cardiac/metabolism, Natriuretic Peptide, Brain/genetics, Obesity/metabolism, Peptide Fragments/metabolism, Prognosis, Protein Processing, Post-Translational, Pulmonary Arterial Hypertension/metabolism, Receptors, Guanylate Cyclase-Coupled/metabolism, Secretory Vesicles/metabolism, Ventricular Remodeling, Water-Electrolyte Balance/physiology

ID: 61253495